Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Catalytic Cross-Coupling/Elimination for Alkene-to-Allene Conversion

Project description

Transforming alkenes into valuable building blocks for medicine

Allenes are highly prized chemical building blocks thanks to their unique, twisted shapes that allow them to interact with biological targets in ways that other molecules cannot. They are traditionally synthesised from high-value alkynes. While it would be more cost-effective to build them from alkenes as they are abundant chemical raw materials, current methods require extreme temperatures and destructive reagents to do this. Supported by the Marie Skłodowska-Curie Actions programme, the Allenes From Alkenes project will introduce a mild, catalytic framework that will transform ordinary alkenes into complex allenes. Using this method to modify the anti-cancer natural product epothilone C, the project will alter the shape of its molecular ring, creating entirely new structures to help discover more potent cancer treatments.

Objective

Allenes are important to investigations in method development, drug discovery, and design of functional materials. While allenes are generated from alkynes, a method that makes it possible to convert alkenes, which are more abundant and less costly than alkyne, to allenes would be of considerable value. However, such methods are rare and those available require relatively forcing conditions and are not catalytic, limiting the applicability in complex molecule synthesis. Inspired by an unexpected recent discovery by the host group, we will develop a catalytic cross-coupling/elimination (CCE) method that will allow for efficient conversion of alkenes to 1,3-disubstituted allenes. The requisite substrates will be accessed either from olefins via cross-metathesis or from boronic acids/esters via cross-coupling. Cross-coupling will involve readily accessible alkenyl boronates are organohalides and cross-metathesis will be promoted by a Ru, or Mo catalysts, most originally developed by the host group. Our investigations will be guided by specific mechanistic attributes of CCE, as identified through preliminary DFT studies. The utility of catalytic CCE will be demonstrated in two ways: by efficient synthesis of bioactive allenes and through late-stage conversion of anti-cancer natural product epothilone C to its corresponding allenyl variants. These latter compounds highlight the fact that allenes represent a stable form of a twisted alkene (neither E or Z). We will show that through CCE uniquely shaped macrocyclic analogs can be obtained and utilized in lead discovery. The present investigations set the stage for eventual development of a catalytic enantioselective version of CCE.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERSITE DE STRASBOURG
Net EU contribution
€ 242 260,56
Address
RUE BLAISE PASCAL 4
67081 Strasbourg
France
Region
Grand Est Alsace Bas-Rhin
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data